Skip to main content

and
  1. Article

    Open Access

    The role of admixture in the rare variant contribution to inflammatory bowel disease

    Identification of rare variants involved in complex, polygenic diseases like Crohn’s disease (CD) has accelerated with the introduction of whole exome/genome sequencing association studies. Rare variants can b...

    Courtney Astore, Shivam Sharma, Sini Nagpal, David J. Cutler in Genome Medicine (2023)

  2. Article

    Open Access

    Altered splicing associated with the pathology of inflammatory bowel disease

    Aberrant splicing of individual genes is a well-known mechanism promoting pathology for a wide range of conditions, but disease is less commonly attributed to global disruption of exon usage. To explore the po...

    Kiera Berger, Hari Somineni, Jarod Prince, Subra Kugathasan, Greg Gibson in Human Genomics (2021)

  3. Article

    Open Access

    Disease-specific regulation of gene expression in a comparative analysis of juvenile idiopathic arthritis and inflammatory bowel disease

    The genetic and immunological factors that contribute to differences in susceptibility and progression between sub-types of inflammatory and autoimmune diseases continue to be elucidated. Inflammatory bowel di...

    Angela Mo, Urko M. Marigorta, Dalia Arafat, Lai Hin Kimi Chan in Genome Medicine (2018)

  4. Article

    Open Access

    A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients

    Inflammatory bowel disease (IBD) is characterized by chronic inflammation of the gastrointestinal tract that is associated with changes in the gut microbiome. Here, we sought to identify strain-specific functi...

    Andrew Brantley Hall, Moran Yassour, Jenny Sauk, Ashley Garner in Genome Medicine (2017)

  5. Article

    Open Access

    Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease

    Gut microbiome dysbiosis has been demonstrated in subjects with newly diagnosed and chronic inflammatory bowel disease (IBD). In this study we sought to explore longitudinal changes in dysbiosis and ascertain ...

    Kelly A. Shaw, Madeline Bertha, Tatyana Hofmekler, Pankaj Chopra in Genome Medicine (2016)